Innophos Holdings’ (NASDAQ:IPHS) “Hold” Rating Reiterated at KeyCorp

Innophos Holdings, Inc. (NASDAQ:IPHS)‘s stock had its “hold” rating reaffirmed by research analysts at KeyCorp in a report issued on Wednesday, November 1st. KeyCorp also issued estimates for Innophos Holdings’ FY2018 earnings at $2.75 EPS.

Several other equities research analysts also recently commented on the stock. Zacks Investment Research raised shares of Innophos Holdings from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. BidaskClub downgraded shares of Innophos Holdings from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th.

Innophos Holdings (IPHS) opened at $44.39 on Wednesday. The company has a quick ratio of 1.49, a current ratio of 2.86 and a debt-to-equity ratio of 0.83. The firm has a market cap of $843.26, a PE ratio of 17.50 and a beta of 0.88. Innophos Holdings has a fifty-two week low of $41.66 and a fifty-two week high of $58.22.

Innophos Holdings (NASDAQ:IPHS) last issued its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.72 by $0.06. The company had revenue of $184.00 million for the quarter, compared to the consensus estimate of $179.33 million. Innophos Holdings had a net margin of 6.19% and a return on equity of 13.90%. The firm’s quarterly revenue was down 1.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.69 EPS. analysts predict that Innophos Holdings will post 2.5 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Innophos Holdings’ (NASDAQ:IPHS) “Hold” Rating Reiterated at KeyCorp” was first published by BBNS and is the sole property of of BBNS. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://baseballnewssource.com/markets/keycorp-reiterates-hold-rating-for-innophos-holdings-inc-iphs/1749319.html.

Several institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. increased its position in shares of Innophos Holdings by 3.8% during the second quarter. BlackRock Inc. now owns 2,432,009 shares of the specialty chemicals company’s stock valued at $106,620,000 after buying an additional 89,360 shares during the period. Vanguard Group Inc. increased its position in shares of Innophos Holdings by 2.9% during the second quarter. Vanguard Group Inc. now owns 1,926,577 shares of the specialty chemicals company’s stock valued at $84,460,000 after buying an additional 54,505 shares during the period. Daruma Capital Management LLC increased its position in shares of Innophos Holdings by 15.5% in the second quarter. Daruma Capital Management LLC now owns 1,182,095 shares of the specialty chemicals company’s stock worth $51,823,000 after purchasing an additional 158,861 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Innophos Holdings by 1.5% in the third quarter. Dimensional Fund Advisors LP now owns 988,323 shares of the specialty chemicals company’s stock worth $48,616,000 after purchasing an additional 14,862 shares during the last quarter. Finally, Frontier Capital Management Co. LLC increased its position in shares of Innophos Holdings by 1.5% in the third quarter. Frontier Capital Management Co. LLC now owns 869,238 shares of the specialty chemicals company’s stock worth $42,758,000 after purchasing an additional 12,808 shares during the last quarter. Hedge funds and other institutional investors own 94.81% of the company’s stock.

About Innophos Holdings

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.